Gilad Shabtai - Net Worth and Insider Trading

Gilad Shabtai Net Worth

The estimated net worth of Gilad Shabtai is at least $57,818 dollars as of 2024-08-26. Gilad Shabtai is the 10% Owner of Eloxx Pharmaceuticals Inc and owns about 83,794 shares of Eloxx Pharmaceuticals Inc (ELOX) stock worth over $57,818. Details can be seen in Gilad Shabtai's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilad Shabtai has not made any transactions after 2018-04-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Gilad Shabtai

To

Gilad Shabtai Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gilad Shabtai owns 1 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) .

Click here to see the complete history of Gilad Shabtai’s form 4 insider trades.

Insider Ownership Summary of Gilad Shabtai

Ticker Comapny Transaction Date Type of Owner
ELOX Eloxx Pharmaceuticals Inc 2018-04-30 10 percent owner

Gilad Shabtai Latest Holdings Summary

Gilad Shabtai currently owns a total of 1 stock. Gilad Shabtai owns 83,794 shares of Eloxx Pharmaceuticals Inc (ELOX) as of April 30, 2018, with a value of $57,818.

Latest Holdings of Gilad Shabtai

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ELOX Eloxx Pharmaceuticals Inc 2018-04-30 83,794 0.69 57,818

Holding Weightings of Gilad Shabtai


Gilad Shabtai Form 4 Trading Tracker

According to the SEC Form 4 filings, Gilad Shabtai has made a total of 0 transactions in Eloxx Pharmaceuticals Inc (ELOX) over the past 5 years. The most-recent trade in Eloxx Pharmaceuticals Inc is the acquisition of 1,875 shares on April 30, 2018, which cost Gilad Shabtai around $731,250.

Insider Trading History of Gilad Shabtai

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gilad Shabtai Trading Performance

GuruFocus tracks the stock performance after each of Gilad Shabtai's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gilad Shabtai is 23.39%. GuruFocus also compares Gilad Shabtai's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gilad Shabtai within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gilad Shabtai's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gilad Shabtai

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.13 LIMIT LIMIT LIMIT LIMIT LIMIT

Gilad Shabtai Ownership Network

Ownership Network List of Gilad Shabtai

No Data

Ownership Network Relation of Gilad Shabtai

Insider Network Chart

Gilad Shabtai Owned Company Details

What does Eloxx Pharmaceuticals Inc do?

Who are the key executives at Eloxx Pharmaceuticals Inc?

Gilad Shabtai is the 10 percent owner of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include HEAD OF R&D Vijay Modur , director & PRESIDENT AND CEO Sumit Aggarwal , and Chief Financial Officer Daniel E. Geffken .

Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eloxx Pharmaceuticals Inc Insider Transactions

No Available Data

Gilad Shabtai Mailing Address

Above is the net worth, insider trading, and ownership report for Gilad Shabtai. You might contact Gilad Shabtai via mailing address: Unit 2706 Michelangelo Towers, 8 Maude Street, Sandton T3 2416.

Discussions on Gilad Shabtai

No discussions yet.